Literature DB >> 9003365

Biochemical characterization and deletion analysis of recombinant human protein phosphatase 2C alpha.

A E Marley1, J E Sullivan, D Carling, W M Abbott, G J Smith, I W Taylor, F Carey, R K Beri.   

Abstract

The use of protein phosphatase inhibitors has been instrumental in defining the intracellular roles of protein phosphatase 1 (PP1), PP2A and PP2B. Identification of the role of PP2C in vivo has been hampered, in part, by the unavailability of specific inhibitors. In order to facilitate the identification of novel and specific inhibitors of PP2C by random screening of compounds, and to further characterize this enzyme at the molecular level by site-directed mutagenesis and X-ray crystallography, we have expressed active recombinant human PP2C alpha (rPP2C alpha) in Escherichia coli. Biochemical characterization of rPP2C alpha showed that it could hydrolyse p-nitrophenyl phosphate (pNPP) although, in contrast with native PP2C, this was not stimulated by Mg2+. As with native PP2C, okadaic acid failed to inhibit rPP2C alpha, whereas 50 mM NaF dramatically inhibited its activity. An alignment of the amino acid sequence of AMP-activated protein kinase (AMPK) with those of other serine/threonine protein kinases around the regulatory phosphorylation site (subdomains VII-VIII) revealed a high degree of conservation. Phosphopeptides derived from this region of AMPK and containing the almost invariant threonine (Thr172 in AMPK) were found to be good substrates for rPP2C alpha. We also showed that rPP2C alpha can inactivate AMPK, but only in the presence of Mg2+. To define the regions of PP2C alpha important for catalytic activity, we expressed a number of truncated proteins based on the sequence and proposed domain structure of the PP2C alpha homologue from Paramecium tetraurelia. Deletion of 75 residues (9 kDa) from the C-terminus appeared to have little effect on the catalytic activity using pNPP, phosphopeptides or AMPK as substrates. This suggests that the residues important in catalysis lie elsewhere in the protein. A further deletion of the C-terminus led to a completely inactive and very poorly soluble protein.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 9003365      PMCID: PMC1218000          DOI: 10.1042/bj3200801

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  37 in total

1.  Identification of two isoenzymes of protein phosphatase 2C in both rabbit skeletal muscle and liver.

Authors:  C H McGowan; P Cohen
Journal:  Eur J Biochem       Date:  1987-08-03

2.  Inhibitory effect of a marine-sponge toxin, okadaic acid, on protein phosphatases. Specificity and kinetics.

Authors:  C Bialojan; A Takai
Journal:  Biochem J       Date:  1988-11-15       Impact factor: 3.857

Review 3.  Phosphoprotein phosphatases.

Authors:  H C Li
Journal:  Curr Top Cell Regul       Date:  1982

4.  The protein phosphatases involved in cellular regulation. 6. Measurement of type-1 and type-2 protein phosphatases in extracts of mammalian tissues; an assessment of their physiological roles.

Authors:  T S Ingebritsen; A A Stewart; P Cohen
Journal:  Eur J Biochem       Date:  1983-05-02

5.  Protein phosphatases: properties and role in cellular regulation.

Authors:  T S Ingebritsen; P Cohen
Journal:  Science       Date:  1983-07-22       Impact factor: 47.728

6.  A malachite green procedure for orthophosphate determination and its use in alkaline phosphatase-based enzyme immunoassay.

Authors:  A A Baykov; O A Evtushenko; S M Avaeva
Journal:  Anal Biochem       Date:  1988-06       Impact factor: 3.365

7.  Molecular cloning of rat type 2C (IA) protein phosphatase mRNA.

Authors:  S Tamura; K R Lynch; J Larner; J Fox; A Yasui; K Kikuchi; Y Suzuki; S Tsuiki
Journal:  Proc Natl Acad Sci U S A       Date:  1989-03       Impact factor: 11.205

8.  5'-AMP inhibits dephosphorylation, as well as promoting phosphorylation, of the AMP-activated protein kinase. Studies using bacterially expressed human protein phosphatase-2C alpha and native bovine protein phosphatase-2AC.

Authors:  S P Davies; N R Helps; P T Cohen; D G Hardie
Journal:  FEBS Lett       Date:  1995-12-27       Impact factor: 4.124

9.  Human liver phosphatase 2A: cDNA and amino acid sequence of two catalytic subunit isotypes.

Authors:  J Arino; C W Woon; D L Brautigan; T B Miller; G L Johnson
Journal:  Proc Natl Acad Sci U S A       Date:  1988-06       Impact factor: 11.205

10.  The protein phosphatases involved in cellular regulation. 3. Fatty acid synthesis, cholesterol synthesis and glycolysis/gluconeogenesis.

Authors:  T S Ingebritsen; J Blair; P Guy; L Witters; D G Hardie
Journal:  Eur J Biochem       Date:  1983-05-02
View more
  31 in total

1.  Evolution of the metazoan protein phosphatase 2C superfamily.

Authors:  Adi Stern; Eyal Privman; Michal Rasis; Sara Lavi; Tal Pupko
Journal:  J Mol Evol       Date:  2006-12-06       Impact factor: 2.395

2.  Identification of a novel PP2C-type mitochondrial phosphatase.

Authors:  Mandar Joshi; Nam Ho Jeoung; Kirill M Popov; Robert A Harris
Journal:  Biochem Biophys Res Commun       Date:  2007-02-28       Impact factor: 3.575

3.  Investigating the regulation of brain-specific kinases 1 and 2 by phosphorylation.

Authors:  Nicola J Bright; David Carling; Claire Thornton
Journal:  J Biol Chem       Date:  2008-03-13       Impact factor: 5.157

4.  The type 2C Ser/Thr phosphatase PP2Cgamma is a pre-mRNA splicing factor.

Authors:  M V Murray; R Kobayashi; A R Krainer
Journal:  Genes Dev       Date:  1999-01-01       Impact factor: 11.361

5.  Enzymatic and functional analysis of a protein phosphatase, Pph3, from Myxococcus xanthus.

Authors:  Yoshio Kimura; Yumi Mori; Youhei Ina; Kaoru Takegawa
Journal:  J Bacteriol       Date:  2011-03-11       Impact factor: 3.490

6.  FIN13, a novel growth factor-inducible serine-threonine phosphatase which can inhibit cell cycle progression.

Authors:  M A Guthridge; P Bellosta; N Tavoloni; C Basilico
Journal:  Mol Cell Biol       Date:  1997-09       Impact factor: 4.272

7.  Identification of a selective small-molecule inhibitor series targeting the eyes absent 2 (Eya2) phosphatase activity.

Authors:  Aaron B Krueger; Seameen J Dehdashti; Noel Southall; Juan J Marugan; Marc Ferrer; Xueni Li; Heide L Ford; Wei Zheng; Rui Zhao
Journal:  J Biomol Screen       Date:  2012-07-20

8.  AMP-activated protein kinase (AMPK) cross-talks with canonical Wnt signaling via phosphorylation of beta-catenin at Ser 552.

Authors:  Junxing Zhao; Wanfu Yue; Mei J Zhu; Nair Sreejayan; Min Du
Journal:  Biochem Biophys Res Commun       Date:  2010-03-31       Impact factor: 3.575

Review 9.  D-chiro-inositol glycans in insulin signaling and insulin resistance.

Authors:  Joseph Larner; David L Brautigan; Michael O Thorner
Journal:  Mol Med       Date:  2010-08-27       Impact factor: 6.354

Review 10.  Maternal obesity, inflammation, and fetal skeletal muscle development.

Authors:  Min Du; Xu Yan; Jun F Tong; Junxing Zhao; Mei J Zhu
Journal:  Biol Reprod       Date:  2009-06-10       Impact factor: 4.285

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.